vs
Side-by-side financial comparison of Invesco (IVZ) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
Invesco is the larger business by last-quarter revenue ($1.7B vs $1.4B, roughly 1.2× SELECT MEDICAL HOLDINGS CORP). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs -58.9%, a 60.3% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $5.2M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 2.8%).
Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
IVZ vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.4B |
| Net Profit | $-995.9M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | -86.2% | 4.6% |
| Net Margin | -58.9% | 1.4% |
| Revenue YoY | 6.2% | 6.4% |
| Net Profit YoY | -575.8% | 225.7% |
| EPS (diluted) | $-2.61 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.5B | $1.3B | ||
| Q1 24 | $1.5B | $1.3B |
| Q4 25 | $-995.9M | $20.2M | ||
| Q3 25 | $356.4M | $28.8M | ||
| Q2 25 | $197.4M | $40.6M | ||
| Q1 25 | $171.1M | $56.7M | ||
| Q4 24 | $209.3M | $-16.1M | ||
| Q3 24 | $55.0M | $55.6M | ||
| Q2 24 | $132.2M | $77.6M | ||
| Q1 24 | $141.5M | $96.9M |
| Q4 25 | -86.2% | 4.6% | ||
| Q3 25 | 16.5% | 5.4% | ||
| Q2 25 | 14.1% | 6.5% | ||
| Q1 25 | 18.1% | 8.3% | ||
| Q4 24 | 19.6% | 1.6% | ||
| Q3 24 | 6.6% | 4.3% | ||
| Q2 24 | 13.9% | 5.8% | ||
| Q1 24 | 14.4% | 9.0% |
| Q4 25 | -58.9% | 1.4% | ||
| Q3 25 | 21.7% | 2.1% | ||
| Q2 25 | 13.0% | 3.0% | ||
| Q1 25 | 11.2% | 4.2% | ||
| Q4 24 | 13.1% | -1.2% | ||
| Q3 24 | 3.6% | 4.4% | ||
| Q2 24 | 8.9% | 6.1% | ||
| Q1 24 | 9.6% | 7.3% |
| Q4 25 | $-2.61 | $0.17 | ||
| Q3 25 | $0.66 | $0.23 | ||
| Q2 25 | $-0.03 | $0.32 | ||
| Q1 25 | $0.38 | $0.44 | ||
| Q4 24 | $0.46 | $-0.12 | ||
| Q3 24 | $0.12 | $0.43 | ||
| Q2 24 | $0.29 | $0.60 | ||
| Q1 24 | $0.31 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $26.5M |
| Total DebtLower is stronger | $1.8B | $1.8B |
| Stockholders' EquityBook value | $12.2B | $1.7B |
| Total Assets | $27.1B | $5.9B |
| Debt / EquityLower = less leverage | 0.15× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.0B | $26.5M | ||
| Q3 25 | $973.1M | $60.1M | ||
| Q2 25 | $922.7M | $52.3M | ||
| Q1 25 | $821.7M | $53.2M | ||
| Q4 24 | $986.5M | $59.7M | ||
| Q3 24 | $1.0B | $191.5M | ||
| Q2 24 | $878.5M | $111.2M | ||
| Q1 24 | $895.7M | $92.6M |
| Q4 25 | $1.8B | $1.8B | ||
| Q3 25 | $1.6B | $1.7B | ||
| Q2 25 | $1.9B | $1.8B | ||
| Q1 25 | $964.8M | $1.8B | ||
| Q4 24 | $890.6M | $1.7B | ||
| Q3 24 | $890.3M | $3.1B | ||
| Q2 24 | $890.1M | $3.6B | ||
| Q1 24 | $1.3B | $3.8B |
| Q4 25 | $12.2B | $1.7B | ||
| Q3 25 | $14.0B | $1.7B | ||
| Q2 25 | $13.9B | $1.7B | ||
| Q1 25 | $14.7B | $1.7B | ||
| Q4 24 | $14.6B | $1.7B | ||
| Q3 24 | $14.8B | $1.9B | ||
| Q2 24 | $14.6B | $1.4B | ||
| Q1 24 | $14.6B | $1.4B |
| Q4 25 | $27.1B | $5.9B | ||
| Q3 25 | $28.4B | $5.7B | ||
| Q2 25 | $28.5B | $5.7B | ||
| Q1 25 | $28.1B | $5.7B | ||
| Q4 24 | $27.0B | $5.6B | ||
| Q3 24 | $27.5B | $8.0B | ||
| Q2 24 | $27.2B | $7.9B | ||
| Q1 24 | $28.1B | $7.9B |
| Q4 25 | 0.15× | 1.06× | ||
| Q3 25 | 0.12× | 1.03× | ||
| Q2 25 | 0.14× | 1.10× | ||
| Q1 25 | 0.07× | 1.03× | ||
| Q4 24 | 0.06× | 1.01× | ||
| Q3 24 | 0.06× | 1.62× | ||
| Q2 24 | 0.06× | 2.54× | ||
| Q1 24 | 0.09× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $455.8M | $64.3M |
| Free Cash FlowOCF − Capex | $432.2M | $5.2M |
| FCF MarginFCF / Revenue | 25.5% | 0.4% |
| Capex IntensityCapex / Revenue | 1.4% | 4.2% |
| Cash ConversionOCF / Net Profit | — | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $1.4B | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $455.8M | $64.3M | ||
| Q3 25 | $606.2M | $175.3M | ||
| Q2 25 | $547.9M | $110.3M | ||
| Q1 25 | $-84.6M | $-3.5M | ||
| Q4 24 | $316.9M | $125.4M | ||
| Q3 24 | $438.4M | $181.0M | ||
| Q2 24 | $489.1M | $278.2M | ||
| Q1 24 | $-54.4M | $-66.7M |
| Q4 25 | $432.2M | $5.2M | ||
| Q3 25 | $586.4M | $122.2M | ||
| Q2 25 | $530.4M | $45.6M | ||
| Q1 25 | $-108.0M | $-55.8M | ||
| Q4 24 | $309.9M | $62.0M | ||
| Q3 24 | $410.0M | $130.3M | ||
| Q2 24 | $462.4M | $222.6M | ||
| Q1 24 | $-75.4M | $-119.2M |
| Q4 25 | 25.5% | 0.4% | ||
| Q3 25 | 35.7% | 9.0% | ||
| Q2 25 | 35.0% | 3.4% | ||
| Q1 25 | -7.1% | -4.1% | ||
| Q4 24 | 19.5% | 4.7% | ||
| Q3 24 | 27.1% | 10.2% | ||
| Q2 24 | 31.2% | 17.4% | ||
| Q1 24 | -5.1% | -9.0% |
| Q4 25 | 1.4% | 4.2% | ||
| Q3 25 | 1.2% | 3.9% | ||
| Q2 25 | 1.2% | 4.8% | ||
| Q1 25 | 1.5% | 3.9% | ||
| Q4 24 | 0.4% | 4.8% | ||
| Q3 24 | 1.9% | 4.0% | ||
| Q2 24 | 1.8% | 4.3% | ||
| Q1 24 | 1.4% | 4.0% |
| Q4 25 | — | 3.19× | ||
| Q3 25 | 1.70× | 6.09× | ||
| Q2 25 | 2.78× | 2.72× | ||
| Q1 25 | -0.49× | -0.06× | ||
| Q4 24 | 1.51× | — | ||
| Q3 24 | 7.97× | 3.25× | ||
| Q2 24 | 3.70× | 3.59× | ||
| Q1 24 | -0.38× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IVZ
| Investment Advice | $1.2B | 73% |
| Distribution And Shareholder Service | $382.7M | 23% |
| Financial Service Other | $51.0M | 3% |
| Investment Performance | $28.9M | 2% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
